Sino Biopharmaceutical (HK:1177) has released an update.
Sino Biopharmaceutical Limited has released an update detailing the composition of its Board of Directors, which includes six executive directors and five independent non-executive directors. The announcement also outlines the establishment of five committees within the board, each with designated chairpersons and members. This reorganization aims to bolster the company’s governance and oversight.
For further insights into HK:1177 stock, check out TipRanks’ Stock Analysis page.
